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Abstract
Currently, our knowledge of how pathogenic fungi grow in mammalian host environments is limited. Using a
chemotherapeutic murine model of invasive pulmonary aspergillosis (IPA) and
1H-NMR metabolomics, we detected ethanol
in the lungs of mice infected with Aspergillus fumigatus. This result suggests that A. fumigatus is exposed to oxygen
depleted microenvironments during infection. To test this hypothesis, we utilized a chemical hypoxia detection agent,
pimonidazole hydrochloride, in three immunologically distinct murine models of IPA (chemotherapeutic, X-CGD, and
corticosteroid). In all three IPA murine models, hypoxia was observed during the course of infection. We next tested the
hypothesis that production of ethanol in vivo by the fungus is involved in hypoxia adaptation and fungal pathogenesis.
Ethanol deficient A. fumigatus strains showed no growth defects in hypoxia and were able to cause wild type levels of
mortality in all 3 murine models. However, lung immunohistopathology and flow cytometry analyses revealed an increase in
the inflammatory response in mice infected with an alcohol dehydrogenase null mutant strain that corresponded with a
reduction in fungal burden. Consequently, in this study we present the first in vivo observations that hypoxic
microenvironments occur during a pulmonary invasive fungal infection and observe that a fungal alcohol dehydrogenase
influences fungal pathogenesis in the lung. Thus, environmental conditions encountered by invading pathogenic fungi may
result in substantial fungal metabolism changes that influence subsequent host immune responses.
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Introduction
The incidence of life-threatening human fungal infections has
increased during the last three decades as medical therapies, organ
transplantations, an increasing geriatric population, and HIV
infections have generated a significant rise in the number of
susceptible patients [1,2,3]. Aspergillus fumigatus, a commonly
encountered mold found in soil and organic debris [4,5], is
responsible for a number of clinically relevant diseases in
immunocompromised and immunocompetent individuals. Among
these, invasive pulmonary aspergillosis (IPA) is the most lethal with
mortality rates ranging from 30–90% depending on the patient
population [6,7,8,9,10,11].
To cause lethal disease, A. fumigatus must face and overcome a
number of in vivo microenvironment challenges once it is inhaled
into the lower respiratory tract. However, our understanding of
the dynamic microenvironments encountered by the fungus in the
mammalian lung, and the mechanisms by which it grows in these
microenvironments, are poorly understood. Arguably, under-
standing the mechanisms by which A. fumigatus is able to grow in
the mammalian host environment will lead to either improvement
of existing therapeutic options or development of novel treatments
through the identification of novel drug targets. Some of the
previously studied environmental factors encountered by A.
fumigatus during in vivo growth include: high temperature, changes
in pH, oxidative stress, and a restricted nutrient supply. In all
probability, these stresses are similar to those that the mold has to
overcome to be a highly competitive member of the compost
microflora, and subsequently it has evolved multi-faceted and
robust mechanisms to overcome these challenges [12,13,14,15,16].
An important characteristic of A. fumigatus’s saprophytic lifestyle
that has largely been overlooked is its ability to adapt to a wide
range of oxygen levels. Aspergillus species are generally considered
obligate aerobes, but A. fumigatus has been observed to tolerate
oxygen levels as low as 0.1% [17,18]. In compost piles, oxygen
concentrations range from atmospheric (21%) to hypoxic (1.5%
and lower) and rapidly change with the metabolic activity of the
compost microflora [19]. Thus, organisms such as A. fumigatus that
thrive in such environments likely have evolved mechanisms to
tolerate hypoxia. With regard to fungal-human interactions,
oxygen availability in mammalian tissues is also substantially
below atmospheric levels [20,21,22]. Even in the alveoli of healthy
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deposition, the oxygen level is around 14%. By the time oxygen
reaches the capillaries and diffuses into surrounding tissues its
availability is much lower with levels of 2–4% reported [23,24].
Thus, microorganisms that colonize, inhabit and infect mamma-
lian hosts are subject to dynamic ranges of oxygen availability
depending on their location in the mammalian body. Moreover,
the collateral effects of microbial infections, inflammation,
thrombosis, and necrosis, are often thought to decrease available
oxygen concentrations even further [25,26,27,28]. However, the
occurrence and effects of hypoxia on the outcome of human fungal
infections, especially those that primarily occur in the lung, are
poorly understood [29,30].
Recent evidence supporting the hypothesis that hypoxia is a
significant component of fungal pathogenesis comes from studies
on the sterol-regulatory element binding protein (SREBP)
transcription factor in Cryptococcus neoformans and A. fumigatus. Null
mutants of the respective SREBP in each fungal pathogen were
incapable of growth in hypoxic conditions and subsequently were
also avirulent in murine models of cryptococcosis and IPA
[31,32,33]. Though the virulence defect in these SREBP mutants
may be caused by other pleiotropic factors, their ability to grow in
normoxic but not hypoxic conditions strongly suggests that
adaptation and growth in hypoxia are contributing factors to the
avirulence of these strains. Yet, as mentioned, whether hypoxia
occurs during an invasive fungal infection in commonly used
murine models of fungal disease is unknown.
In this study, we observe for the first time that hypoxic
microenvironments do occur in three immunologically distinct
murine models of IPA. We also observe that a key gene, which
encodes an enzyme required for the last step of ethanol
fermentation in response to hypoxia, influences IPA pathogenesis
through modulation of the inflammatory response. Thus, we
conclude that in vivo hypoxic microenvironments do occur during
IPA and that fungal responses to these conditions can influence
fungal pathogenesis. These results lay the foundation for further
studies to identify how human pathogenic fungi adapt to hypoxia
and how these adaptation mechanisms ultimately influence the
outcome of fungal pathogenesis in mammals.
Results
In vivo ethanol production by A. fumigatus in a murine
model of invasive pulmonary aspergillosis
In order to gain an understanding of the important metabolic
pathways utilized by Aspergillus fumigatus during growth in the
mammalian lung, we examined qualitative production of metab-
olites in a chemotherapeutic murine model of invasive pulmonary
aspergillosis (IPA) utilizing broncheoalveolar lavages (BAL) and
1H-NMR. Our chemotherapeutic model of IPA is characterized
by the use of cyclophosphamide and the corticosteroid triamcin-
olone to induce immunosuppression. Visual inspection of the BAL
sample spectra taken from uninfected control mice and mice
inoculated with A. fumigatus on day +3 post-inoculation revealed a
relatively small number of identifiable metabolites and few
differences. Identifiable metabolites in all samples included
taurine, choline, creatine, acetate, and lactate (Figure S1). Given
the low complexity of BAL samples that are predominately 0.7%
saline, this result is not surprising. Surprisingly, however, ethanol
was detected in 4 of the 10 mice infected with A. fumigatus, but in
none of the uninfected controls (Figure S1). Attempts to detect
ethanol at later time points during infection using BALs or lung
homogenates were not successful. Thus, the extent of ethanol
production in vivo during IPA remains to be determined.
However, to support the hypothesis that the ethanol production
was fungal in origin, we next tested whether A. fumigatus was
capable of fermenting glucose to ethanol in vitro in glucose minimal
media (1% glucose) under normoxic or hypoxic conditions. While
no ethanol was detectable after 24 h in either condition, we could
detect ethanol in the culture supernatants after 48, 72, and 96 h of
growth in hypoxia (1% oxygen, Figure 1). The glucose levels
expectedly dropped during the time course of the shake flask
cultures, from 55 mM at time zero to less than 4 mM at 96 h, and
this corresponded with a decrease in detectable ethanol (Figure 1).
Fermentation is associated with hypoxic or anoxic environments in
many organisms including plant pathogenic fungi, Crabtree
negative yeast, pathogenic bacteria, and even plants
[34,35,36,37,38,39,40]. We thus hypothesized that A. fumigatus
encounters hypoxic or anoxic microenvironments during IPA.
Hypoxia occurs in murine models of invasive pulmonary
aspergillosis
To test the hypothesis that A. fumigatus encounters hypoxia
during IPA, we used a hypoxia marker, pimonidazole hydrochlo-
ride, a nitroheterocyclic drug whose hypoxia-dependent activation
by cellular mammalian nitroreductases (severe hypoxia: 10 mmHg
partial oxygen pressure, #1% oxygen) leads to the formation of
covalent intracellular adducts with thiol groups on proteins,
peptides, amino acids, and the drug itself [41,42,43,44]. The
resulting protein adducts are effective immunogens and can be
used to ‘‘visualize’’ hypoxia in vivo with immunofluorescence.
We tested for the development of hypoxia in vivo in three
immunologically distinct murine models of IPA (chemotherapeu-
tic, corticosteroid, and X-CGD) (Figure 2). Each model represents
a different clinically relevant mechanism of immunosuppression.
As mentioned, the chemotherapeutic model attempts to reproduce
the immunological state of severely immunosuppressed patients
who have often undergone a bone marrow transplant. This model
is characterized by a severe depletion of neutrophils and other
important immune effector cells needed to prevent and control
Author Summary
Metabolic flexibility is important for human pathogens like
Aspergillus fumigatus as it allows adaptation to dynamic
infection induced microenvironments. Consequently, iden-
tification of fungal metabolic pathways critical for in vivo
growth may uncover novel virulence mechanisms and new
therapeutic opportunities. To date, the mechanisms used
by A. fumigatus to adapt to microenvironments in
immunosuppressed mammalian hosts are poorly under-
stood. In this study we discover that A. fumigatus is
exposed to oxygen limiting microenvironments during
invasive pulmonary aspergillosis (IPA). Thus, this result
builds on growing evidence that suggests hypoxia is a
significant in vivo stress encountered by human fungal
pathogens. We tested the hypothesis that genes encoding
enzymes involved in ethanol fermentation are important
for in vivo fungal responses to hypoxia. We consequently
observed a significant increase in the inflammatory
response that correlated with reduced fungal growth in
the lungs of mice inoculated with an alcohol dehydroge-
nase null mutant. Altogether, our study suggests that
fungal responses to in vivo hypoxic microenvironments
can directly affect host immune responses to the invading
fungal pathogen. A better understanding of these
mechanisms will increase our understanding of IPA and
other human diseases caused by fungi and could
potentially lead to improved therapeutic options.
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susceptible to invasive fungal infections is those patients on high
doses of corticosteroids for treatment of graft versus host disease or
other autoimmune type diseases. In our model of this patient
population, we utilized a single high dose of the corticosteroid
triamcinolone. Unlike the chemotherapeutic model, this model is
not characterized by depletion of effector cells, but rather by a
suppression of their antifungal activity that leads to altered
inflammatory responses. Finally, we utilized transgenic mice that
are deficient in the gp91 Phox subunit of the NADPH oxidase.
These mice are a close model for the genetic disorder chronic
granulomatous disease (CGD), and are highly susceptible to
Aspergillus infection.
In the Triamcinolone model, histopathology of A. fumigatus
inoculated mice show lesions with a strong influx of immune cells
(blue) and strong growth of fungal hyphae (green) invading into the
lung parenchyma from the airways (Figure 2A, Figure S2). By day
3 p.i., hypoxia could readily be detected in the center of larger
lesions (red), and while the hypoxic areas of the lesions are
comparable on day 3.5 p.i., they are significantly expanded on day
4 p.i.. The isotype control staining of the same lesions in
subsequent tissue sections, as well as complete staining of tissue
sections from inoculated mice without hypoxyprobe injections,
demonstrate the specificity of the hypoxyprobe and antibodies
utilized (Figure 2A).
In contrast to the Triamcinolone model, lesions in the
chemotherapeutic model are dominated by massive fungal growth
causing significant tissue necrosis with minimal inflammation
(Figure 2B, Figure S2). Given the severe neutropenia associated
with this model, this result is expected. Despite the strong
reduction in the inflammatory response and extensive fungal
growth in this model, we were able to detect hypoxia in these
lesions at similar time points to the Triamcinolone model
(Figure 2A and B). However, it is clear that the amount and
extent of hypoxia is significantly reduced in this murine model.
In mice that lack the gp91
phox component of NADPH oxidase (a
model of X-CGD) the lesion size gradually increased during the
time course of infection from day 3 to day 5, which was due to a
strong increase in the inflammatory response of the host [45].
Fungal growth in this model was strongly reduced in comparison
to the other two tested murine models (Figure 2C, Figure S2). On
day 3 p.i. minimal amounts of hypoxia were detected, but by day 4
p.i. significant levels of hypoxia were observed in the center of the
lesions. On day 5 p.i. hypoxia was abundantly present in the
center of the lesions, and throughout the surrounding tissue
indicating that significant parts of the lung experience hypoxia in
this murine model of IPA (Figure 2C). Indeed, in some animals in
this model almost the entire lung seemed hypoxic at later time
points just prior to mortality (data not shown). Taken together,
these data confirm that A. fumigatus encounters hypoxic microen-
vironments (oxygen concentrations #1%) and a dynamic range of
oxygen availability during murine models of IPA. The extent of
hypoxia, fungal growth, and host immune responses in the
different models suggests that the host inflammatory response
plays an important, but not exclusive, role in the generation of the
hypoxic microenvironment.
Generation and characterization of ethanol fermentation
deficient mutants
Given the evidence that A. fumigatus encounters hypoxia during
IPA and that production of ethanol occurs in vivo during infection
and is normally used by microbes to survive in low oxygen
environments [34,35,36,37,38,39], we next tested the hypothesis
that ethanol fermentation was a key mechanism for hypoxia
adaptation and fungal virulence.
To determine the effects of ethanol fermentation on IPA
pathogenesis, we searched the A. fumigatus genome sequence for
genes encoding enzymes known to be involved in ethanol
fermentation [46,47]. Using the A. nidulans pdcA (pyruvate
decarboxylase) (An_pdcA – AN4888) gene sequence for a BLASTX
search of the A. fumigatus genome (CADRE genome database) we
identified three potential candidates that may encode for pyruvate
decarboxylases and named them pdcA (AFUB_038070: 85%
identity to An_pdcA), pdcB (AFUB_096720: 39% identity to
An_pdcA), and pdcC (AFUB_062480: 33% identity to An_pdcA)
(Table 1). Protein sequence analysis (InterProScan Sequence
Search, http://www.ebi.ac.uk/Tools/InterProScan/) suggested
all three A. fumigatus proteins were pyruvate decarboxylases
Figure 1. Culture supernatants were used in a high performance liquid chromatography (HPLC) analysis to determine ethanol
production and glucose consumption. After 48 hours under hypoxic conditions, ethanol was detected along with a decrease in glucose
concentration. Ethanol concentrations decrease over time with a peak at 48 hours. Each value represents mean 6 standard error (n=2 independent
cultures). *,**,#p,0.05.
doi:10.1371/journal.ppat.1002145.g001
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PLoS Pathogens | www.plospathogens.org 3 July 2011 | Volume 7 | Issue 7 | e1002145Figure 2. Identification of hypoxic microenvironments at the site of A. fumigatus infections in murine lungs. The following three distinct
mouse IPA models were utilized: (A) triamcinolone (corticosteroid) model, (B) chemotherapy model, and (C) X-CGD mouse model. Mice were
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(Adh) gene sequences of A. nidulans (AdhI: An_alcA – AN8979,
AdhII: An_alcB – AN3741, and AdhIII: An_alcC – AN2286) were
used to identify the most likely genes encoding alcohol dehydro-
genases in A. fumigatus. However, as the Aspergillus fumigatus genome
contains several predicted alcohol dehydrogenases we restricted
our search to proteins with high identity and similarity to the A.
nidulans Adh proteins (alcA – AFUB_087590: 87% identity and
94% similarity to An_alcA, alcB – AFUB_089920: 79% identity and
89% similarity to An_alcB, and alcC – AFUB_053780: 80%
identity and 91% similarity to An_alcC) (Table 1).
Given the findings that A. fumigatus utilizes ethanol fermentation
in in vitro and possibly in vivo hypoxic environments and the
apparent gene redundancy in the predicted ethanol fermentation
pathway, we next sought to determine which of the genes
transcriptionally responds to hypoxia. Quantitative real-time PCR
comparing the mRNA abundance of the ethanol fermentation
genes under hypoxic and normoxic conditions revealed an
immediate increase in mRNA abundance of all three pdc genes
as well as the alcC gene to hypoxic growth conditions (Figure 3).
While mRNA abundance levels of pdcB and pdcC show a ,9-fold
higher normalized fold expression after 24 h in hypoxia, pdcA
mRNA showed a 64-fold increase compared to normoxic culture
conditions. This data suggest that PdcA is the primary pyruvate
decarboxylase that responds to hypoxia in A. fumigatus. With
regard to the alcohol dehydrogenase encoding genes, the mRNA
abundance of alcC significantly increased in response to hypoxia
while mRNA abundance of the other two alcohol dehydrogenase
encoding genes did not (Figure 3). These data suggest that alcC is
the primary gene encoding an alcohol dehydrogenase that
responds to hypoxia in A. fumigatus.
To determine whether these genes are involved in ethanol
fermentation, we generated null mutants of the genes encoding
PdcA, PdcB, PdcC, and AlcC by replacement of the coding
sequence in A. fumigatus strain CEA17 with the auxotrophic marker
pyrG from A. parasiticus (Figure 4 and data not shown). A pdcA/
pdcB double mutant was also generated. Ectopic re-introduction of
the wild type pdcA and alcC allele into DpdcA and DalcC (resulting in
strains pdcA recon and alcC recon) allowed us to attribute all
resulting phenotypes specifically to the absence of pdcA or alcC.
The genotype of all strains was confirmed with PCR analyses (data
not shown) and Southern blots (Figure 4 and data not shown).
Southern blot analysis of the alcC recon strain revealed a double
insertion of the alcC encoding sequence in the genome and the alcC
recon strain displayed a 10-fold higher mRNA abundance in
response to hypoxia as the alcC allele in the wild type strain (data
not shown). However, the double insertion had no detectable
phenotypic effect on the reconstituted strain, since the alcC recon
strain showed the same phenotype as the wild type in all further
experiments with only a slight but statistically insignificant increase
in ethanol production (Figure 5B).
Next, we examined the ability of the generated null mutant
strains to produce ethanol in response to in vitro hypoxic growth
conditions. The loss of pdcA decreases Pdc enzyme activity in
hypoxia by approximately 80% (Figure 5A) and the activity can be
restored to wild type levels in the pdcA recon strain. The DpdcB and
DpdcC, as well as the DalcC strain showed no significant decrease in
Pdc activity (data not shown), confirming the hypothesis that pdcA
is the most important pdc gene in A. fumigatus for production of
ethanol, at least in vitro. However there is still residual activity
detectable in the DpdcA and the DpdcA/DpdcB strains (0.0047 6
0.0041 in normoxia and 0.0039 6 0.0064 in hypoxia; data not
euthanized on indicated days after inoculation (mock control=0.01% Tween inoculated, infected mice=inoculated with A. fumigatus strain CEA10).
Prior to sacrifice, Hypoxyprobe-1 (60 mg/kg) was intravenously injected into indicated mice (+hypoxyprobe) and allowed to circulate for 60 to
90 min. After tissue preparation specific antibodies were used to detect Hypoxyprobe-1 bound to proteins (red) and A. fumigatus hyphae (green).
Isotype controls were only stained with either one of the secondary antibodies to verify specific staining. Host cell nuclei were counterstained with
DAPI (blue). Merged pictures show co-localization of the fungal hyphae (green), surrounding immune cells (blue), and Hypoxyprobe-1 (red) in all
three IPA mouse models. Isotype controls and infected mice without Hypoxyprobe-1 injection show that no unspecific staining occurred.
Bar=100 mm.
doi:10.1371/journal.ppat.1002145.g002
Table 1. Genes involved in A. fumigatus ethanol fermentation pathway.
Gene ID Gene Name Query Gene Similarity Identity Domains Enzyme
AFUB_038070 pdcA AN_pdcA 93% 85% C-terminal TPP-binding, central domain, N-terminal
TPP-binding domain
Pyruvate decarboxylase
AFUB_096720 pdcB AN_pdcA 57% 39% C-terminal TPP-binding, central domain, N-terminal
TPP-binding domain
Pyruvate decarboxylase
AFUB_062480 pdcC AN_pdcA 47% 33% TPP-binding enzyme conserved site, C-terminal
TPP-binding, central domain, N-terminal
TPP-binding domain
Pyruvate decarboxylase
AFUB_087590 alcA AN_alcA 94% 87% zinc-containing conserved site, GroES-like domain,
ADH C-terminal domain, ADH GroES-like domain,
NAD(P)-binding domain
Alcohol Dehydrogenase
AFUB_089920 alcB AN_alcB 89% 79% zinc-containing conserved site, GroES-like domain,
ADH C-terminal domain, ADH GroES-like domain,
NAD(P)-binding domain
Alcohol Dehydrogenase
AFUB_053780 alcC AN_alcC 91% 80% zinc-containing conserved site, GroES-like domain,
ADH C-terminal domain, ADH GroES-like domain,
NAD(P)-binding domain
Alcohol Dehydrogenase
AN=Aspergillus nidulans.
TPP=Thiamine pyrophosphate.
ADH=alcohol dehydrogenase.
doi:10.1371/journal.ppat.1002145.t001
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would need to be generated to definitively answer whether the
observed residual activity from the cell free extracts is indeed real
Pdc activity.
Using the culture supernatants from the above experiments we
examined the amount of ethanol produced by the respective
fungal strains. The pdcB and pdcC null mutant strains show a slight
but statistically insignificant decrease in ethanol production that is
essentially similar to wild type levels (CEA10: 0.07160.035%;
DpdcB: 0.04760.002; DpdcC: 0.04060.006; P.0.4). Importantly,
no ethanol could be detected in DpdcA and DalcC culture
supernatants, while the wild type and respective reconstituted
strains produced ethanol (Figure 5B). These results support the
gene expression and Pdc enzyme activity assays that suggest PdcA
is the primary Pdc and that AlcC is the primary alcohol
dehydrogenase required for in vitro ethanol production in A.
fumigatus. The function of the remaining Pdc and Alc genes in A.
fumigatus thus is not currently clear.
To determine whether ethanol fermentation is important for
growth under hypoxic conditions, we examined radial growth on
solid media under normoxic and hypoxic conditions. As previously
described, A. fumigatus grows well under hypoxic conditions on the
fermentable carbon source glucose [18,31] (Figure 5C). Surpris-
ingly, the ethanol fermentation deficient mutants show no growth
defect on glucose containing media under hypoxic (1% or 0.2%
O2 (data not shown)) conditions compared to the wild type and the
reconstituted strains (Figure 5C). In addition, the wild type and
mutant strains are all also able to grow on the non-fermentable
carbon sources ethanol, lactate and glycerol, although the growth
rate is decreased compared to growth on glucose (data not shown).
Germination rates were the same for all strains utilized and no
defects in conidia viability were observed (data not shown). Liquid
biomass quantification with the respective mutant strains also
revealed no growth differences between wild type and ethanol
deficient strains in hypoxia (data not shown). Taken together, these
results suggest that PdcA and AlcC are the primary enzymes
involved in ethanol fermentation in A. fumigatus, but that other
unidentified mechanisms are utilized to grow under hypoxic
conditions on fermentable carbon sources when ethanol fermen-
tation is not possible.
Deletion of alcohol dehydrogenase III in A. fumigatus
alters the pathogenesis of invasive pulmonary
aspergillosis
Despite the general lack of a pathogenesis associated phenotype
of the in vitro ethanol production deficient strains, ethanol itself has
been observed to have significant immunomodulatory properties
[48,49,50,51,52]. In addition, utilizing quantitative real-time PCR
we found that alcC is expressed in vivo during fungal pathogenesis
on day 3 and 4 post inoculation in the triamcinolone model
(Figure 6) suggesting that this gene and the enzyme it encodes may
be important for in vivo growth. Therefore, we sought to determine
the effects of loss of PdcA and AlcC on the pathogenesis of IPA.
We first examined the virulence of the DpdcA and DalcC strains in
the chemotherapeutic and X-linked chronic granulomatous
disease (X-CGD, gp91
phox2/2 mice) murine models of IPA
[45,53]. Irrespective of the fungal strain, A. fumigatus infected mice,
in both models, displayed well described symptoms of A. fumigatus
infection including hunched posture, ruffled fur, weight loss, and
increased respiration as early as day +2 of inoculation.
Subsequently, no difference in mortality was observed between
the null mutant (DalcC, DpdcA, and DpdcADpdcB) and wild type
strains (Figure 7 and data not shown).
To further examine the impact of the mutant strains on the
pathogenesis of IPA in these murine models, lung histopathology
was performed. Lungs from X-CGD mice displayed the expected
histopathology for this model including a large inflammatory
response with reduced fungal growth (Figure S3). In this model,
histopathology of wild type and DalcC inoculated mice looked
identical at all time points examined (Figure S3). In the
chemotherapy model, pulmonary lesions of wild type infected
Figure 3. Normalized fold expression of pdc genes and alc genes in A. fumigatus under normoxic and hypoxic conditions.( A) mRNA
levels of all three pdc genes increase in hypoxia with pdcA being the most responsive. mRNA levels of the pdc genes show a reduction in hypoxia over
time. (B) Of the three tested alc genes only mRNA from alcC is increased in response to hypoxia. Quantification of mRNA was achieved by
quantitative real-time PCR. Values are normalized to b–tubulin and shown relative to normoxia. Results are the mean and standard deviation of three
replicates.
doi:10.1371/journal.ppat.1002145.g003
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parenchyma with a minimal influx of immune cells but extensive
tissue necrosis, hemorrhaging, edema, and tissue damage
(Figure 8A). Importantly, mice inoculated with DalcC show lesions
with reduced fungal growth and more inflamed tissue compared to
wild type inoculated mice (despite the overall lesion sizes being
comparable between the two inoculation groups) (Figure 8A).
Taken together, this result suggests that AlcC plays a potential role
in the pathogenesis of IPA.
To explore this hypothesis further, we utilized the Triamcin-
olone (corticosteroid) model of IPA. IPA in mice treated with
corticosteroids have previously been observed to induce hyper-
inflammatory responses that are speculated to be the primary
cause of mortality in this model [54]. Thus, we rationalized that
any changes in the inflammatory response to A. fumigatus in the
absence of AlcC would be potentiated in this model. As in the
chemotherapeutic and X-CGD murine models, DalcC infected
animals displayed wild type levels of mortality in the Triamcin-
olone model (Figure 7C). A similar change in gross histopathology
of the Triamcinolone compared to the chemotherapeutic model
infected with the DalcC strain is also observed (Figure 8B).
Consistent with the observations in the chemotherapy model,
DalcC inoculated animals show less fungal growth but increased
levels of inflammation (Figure 8B).
Altogether these observations suggest that loss of AlcC results
in an increased inflammatory response to A. fumigatus.T o
further characterize and quantify these histopathology observa-
tions, we analyzed the cellular infiltrates in BAL fluids of
Triamcinolone treated mice from 2 different inoculation
experiments using flow cytometry and differential cell counts.
On day 3 p.i., DalcC inoculated mice show an increased
quantity of F4/80
+/CD11c
+ cells and a significant increase in
GR-1
+/CD11b
+ cells in the BAL fluids compared to wild type
infected animals (Figure 9A and B, and Figure S4 and S5). F4/
80
+/CD11c
+ cells most likely represent macrophages while GR-
1
+/CD11b
+ cells are most likely neutrophils. As expected,
control mice BALs contained F4/80
+/CD11c
+ cells but nearly
no GR-1
+/CD11b
+ cells. Furthermore, differential cell counts of
BAL fluids revealed that macrophages, monocytes and partic-
ularly neutrophils were the dominant cell types found in the
BAL samples of A. fumigatus inoculated mice. Consistent with the
observed histopathology as well as the flow cytometry data,
differential cell count numbers of neutrophils were significantly
increased in DalcC inoculated mice (p,0.05; Figure 9C and D).
Figure 4. Generation and confirmation of PdcA and AlcC null mutants in A. fumigatus. Schematic of wild type (CEA10), PdcA (A), and AlcC
(B) null mutant genomic loci. (A) Southern blot analysis of wild type, DpdcA, and pdcA recon strains as well as (B) wild type, DalcC, and alcC recon
strains. Genomic DNA from the respective strains was isolated and digested overnight with SalI and NcoI in the case of PdcA and with only NcoI for
AlcC. An approximate 1 kb genomic region was utilized as a probe. The expected hybridization patterns and sizes were observed for all strains tested.
In addition, confirmation of ectopic reconstitution was confirmed by the presence of the wild type locus hybridization signal and persistence of the
null mutant locus. The alcC reconstituted strain showed a double re-insertion of the alcC locus.
doi:10.1371/journal.ppat.1002145.g004
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tions that indicate an increased inflammatory response in mice
infected with DalcC.
To further quantify the differences in immune response to
DalcC, we examined the production of cytokines normally
associated with neutrophil recruitment in mice (murine IL-8
homologs, KC and MIP2). We observed that protein levels of the
two murine neutrophil chemo-attractants KC and MIP-2 were
significantly increased in BALs from DalcC inoculated animals
compared with wild type (Figure 10A and B; p,0.05). IL-6 was
also slightly elevated while TNF-a protein levels were reduced in
comparison to BAL fluids of mice inoculated with the wild type
(Figure 10C and D; p.0.05). Altogether, these results indicate that
loss of AlcC modulates the immune response of the host to A.
fumigatus causing increased recruitment of immune effector cells to
the site of infection, particularly neutrophils, and associated altered
cytokine responses.
The A. fumigatus DalcC strain shows reduced in vivo
fungal growth and causes wild type levels of tissue
damage
The comparison of histopathology between wild type and DalcC
inoculated mice suggested reduced fungal growth by the DalcC
strain in both the chemotherapy and the Triamcinolone murine
models (Figure 8). In order to confirm this important observation,
we quantified the pulmonary fungal burden on days 3 and 4 p.i. by
quantitative RT-PCR. Consistent with the GMS histopathology,
qRT-PCR confirmed a reduced pulmonary fungal burden in mice
inoculated with DalcC compared to wild type (Figure 11). In
addition, we examined LDH (lactate dehydrogenase) and Albumin
Figure 5. PdcA and AlcC are required for in vitro ethanol fermentation but not hypoxic growth of A. fumigatus. (A) After 48 hours in
hypoxia, mycelia were harvested and pyruvate decarboxylase activity (Pdc) of cell free extracts was determined. Compared to CEA10, the DpdcA
strain showed a ,80% reduction of Pdc activity under hypoxic conditions, which could be restored in the reconstituted strain (*,# p,0.01) (B)
Ethanol concentration in culture supernatants was determined with GCMS, showing that PdcA and AlcC are required for ethanol production of A.
fumigatus. Each value represents mean 6 standard error (n=3 for each condition for each strain). (*,# p,0.01). (C) 1x10
6 conidia of CEA10, DpdcA,
pdcA recon, DalcC, and alcC recon were plated on GMM (glucose) plates and incubated at 37uC for 48 h under normoxic or hypoxic conditions. All
strains showed comparable growth and morphology in all tested conditions.
doi:10.1371/journal.ppat.1002145.g005
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caused by DalcC and the wild type strain. Intriguingly, both strains
cause the same levels of LDH and Albumin release on day 3 and 4
post inoculation (Figure 12). Collectively, the lower fungal burden,
the increased host inflammatory response, and the wild type level
of tissue damage in response to DalcC strongly suggest the A.
fumigatus alcohol dehydrogenase, AlcC, plays an important role in
IPA.
The increased inflammatory response of the host to the
DalcC strain is not caused by changes in the cell wall
The observed altered host response and reduced fungal burden
in animals infected with DalcC led us to question the mechanism
behind these phenotypes. As inflammatory responses to fungal
pathogens are often mediated by the fungal cell wall, we tested
whether loss of AlcC resulted in unexpected changes to the cell
wall of this strain that could account for the in vivo phenotypes.
Figure 6. Normalized fold expression of the A. fumigatus alcC gene in vivo during fungal pathogenesis. Outbred CD1 mice were
immunosuppressed by single injection of Triamcinolone (40 mg/kg) 1 day prior to A. fumigatus intranasal inoculation. Lungs were harvested on
indicated days and whole RNA was prepared. Quantification of mRNA was achieved by quantitative real-time PCR using fungal specific primers.
Values are normalized to tefA and shown relative to mock control animals. Results are the mean and standard deviation of three replicates.
doi:10.1371/journal.ppat.1002145.g006
Figure 7. Loss of ethanol fermentation does not affect survival of A. fumigatus infected mice. (A)( B) Outbred CD-1 mice were
immunosuppressed by intraperitoneal (i.p.) injection of 175 mg/kg cyclophosphamide 2 days prior to infection and 150 mg/kg 3 days post-
inoculation, and subcutaneous (s.c.) injection of Triamcinolone (40 mg/kg) 1 day prior to infection and 6 days post-infection. Mice were inoculated
with ,10
4 conidia of the indicated strains by inhalation of an aerosol in a Hinner’s chamber. (C) For the triamcinolone model outbred CD-1 mice were
immunosuppressed on day -1 by s.c. injection of Kenalog (40 mg/kg), followed by inhalation-inoculation with 10
4 conidia on day 0. (D) gp91
phox2/2
mice were challenged intranasally with 10
6 conidia in a volume of 25 ml of the indicated strains. The ethanol deficient mutant strains, DalcC and
DpdcA, showed no difference in mortality compared to the wild type or reconstituted strains in any of the tested IPA models (p.0.2, Log-Rank Test).
10 animals were inoculated per experiment per inoculation group and the experiments were repeated in duplicate.
doi:10.1371/journal.ppat.1002145.g007
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A. fumigatus wild type or DalcC were co-incubated with bone
marrow-derived macrophages (BMMØ) and inflammatory cyto-
kine responses were measured (Figure 13). No differences in the
secretion of TNF-a or MIP-2 by BMMØ were observed to any of
the tested A. fumigatus growth stages with regard to DalcC or wild
type strains. Moreover, no difference in the response to chemical
cell wall perturbing agents (caspofungin and congo red) was
observed with DalcC (data not shown). Thus, our data suggest that
the increased inflammatory response observed in DalcC inoculated
mice is not caused by changes in the fungal cell wall. Thus, the
exact mechanism for the altered pathogenesis in mice inoculated
with DalcC remains to be determined.
Discussion
Metabolic adaptability and flexibility are important attributes
for pathogens to successfully colonize, infect, and cause disease in a
wide range of hosts. Importantly, these processes are dynamic, and
pathogen and host metabolism are likely to change as the result of
the host-pathogen interaction, which alters the localized microen-
vironment. In this study, we present new insights into the
pathogenesis of IPA in commonly used experimental murine
models. We present data that confirms previous circumstantial
data that suggested that hypoxia may be part of the pathogenesis
of IPA [55,56]. To our knowledge, this is the first confirmation of
the occurrence of in vivo hypoxic microenvironments in an invasive
fungal infection. Our results thereby add a ‘‘new’’ in vivo stress to
which human fungal pathogens must adapt to cause lethal disease,
and it will be intriguing to define the occurrence of hypoxia in
other models of human fungal disease.
To determine whether hypoxia actually occurs in the lung
during IPA, we used the hypoxia marker, pimonidazole hydro-
chloride, which is an investigational oncology probe used as a
hypoxia-imaging agent in clinical studies to detect reduced oxygen
concentrations in animal and human tumors [43,44,57,58,59]. In
our study, we observed that lesions in lungs of mice infected with
A. fumigatus are hypoxic, as evidenced by the formation of a stable
adduct between reduced pimonidazole and host proteins at sites of
A. fumigatus infection. However, the extent and timing of hypoxia
development differed between the immunologically distinct
murine models of infection. While hypoxia did occur to some
degree in all three models, the chemotherapy model exhibited the
least amount of hypoxia in terms of size of the hypoxic area in the
lung. This result suggests that the influx and activity of host cells is
a strong contributor to the development of hypoxia. However, the
persistence of hypoxia in this model, albeit not as extensive as in
the other models, also suggests that fungal activities/components
Figure 8. Representative histopathology of the chemotherapy and triamcinolone mouse models 3 and 4 days after inoculation.
Mice were inoculated with 1x10
4 conidia by inhalation (Control =0.01% Tween inoculated), euthanized on indicated days, lungs removed, fixed, and
stained with hematoxylin and eosin (H&E) or Gommori’s methenamine silver (GMS) stain. (A) In the chemotherapy IPA model wild type inoculated
mice show substantial fungal growth and a strongly reduced influx of immune cells, while lesions of DalcC inoculated mice show reduced fungal
growth and an increased inflammatory response on day 3 and day 4 p.i.. (B) Lung histopathology of triamcinolone model mice showed reduced
fungal growth of the wild type with robust inflammation compared to (A) and an even further reduction in growth of DalcC with an apparent
increase in inflammation and cellular influx. Bar=100 mm.
doi:10.1371/journal.ppat.1002145.g008
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observed that A. fumigatus can modulate host angiogenesis by
secretion of secondary metabolites such as gliotoxin, which may
further compromise tissue perfusion and ultimately contribute to
coagulative necrosis, and thus limit oxygen delivery to sites of
infection [60]. Importantly, though hypoxia was not detected on
day +1 or day +2 of infection in any of our models we cannot rule
out, and indeed would expect, that conidia and growing hyphal
tips experience low oxygen tensions as they are engulfed by various
host cells and ultimately penetrate the lung parenchyma and
invade into the vasculature. Thus, we conclude that during
colonization and subsequent infection, A. fumigatus is exposed to a
dynamic range of oxygen levels in the lung.
The significance of hypoxia, and the timing and extent to which
it occurs during IPA, remain important areas of investigation. One
important question that we have started to explore in this study is
related to the potential clinical significance of fungal mechanisms
of hypoxia adaptation. Previous studies in our and other
laboratories with fungal SREBPs have suggested that fungal
adaptation to hypoxia is critical for virulence. If true, these
mechanisms would become an attractive therapeutic target.
However, SREBPs are transcription factors that likely modulate
Figure 9. Characterization of cellular infiltrates in broncheoalveolar (BAL) fluids of triamcinolone immunosuppressed mice. Flow
cytometry was used to identify (A) F4/80
+/CD11c
+ and (B) GR-1
+/CD11b
+ cells. Figures S3 and S4 show the corresponding Dot plots. Both cell types
are elevated in DalcC inoculated mice. In agreement, differential cell counts demonstrate that macrophage and monocyte numbers were slightly
increased in mice inoculated with DalcC (C) while neutrophil numbers were significantly elevated (D). *p,0.05. Results are presented as mean and
standard error of N=5 mice. The experiment was repeated in duplicate with similar results.
doi:10.1371/journal.ppat.1002145.g009
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is not currently possibly to attribute the avirulence phenotype of
these strains solely to their inability to grow in hypoxia. In general,
mechanisms of hypoxia adaptation in human fungal pathogens are
unexplored.
Most eukaryotic cells, like A. fumigatus, obligatorily use oxygen to
carry out many of their biochemical reactions. Oxygen is a key
component of energy production where it functions as a terminal
electron acceptor in the formation of ATP from glucose during
aerobic respiration. When exposed to microenvironments with
limited levels of oxygen, many microorganisms utilize fermenta-
tion as a potential metabolic mechanism for dealing with the lack
of oxygen [34,35,36,37,38,39,40]. Fermentation allows the fungus
to replenish sources of NAD
+ and thus to generate ATP through
continued use of glycolysis. Importantly, our interest in hypoxia
and fungal pathogenesis began with the discovery of ethanol in
BAL samples from A. fumigatus infected mice immunosuppressed
with our chemotherapeutic model (Figure S1). Thus, in this study,
we explored the potential role of ethanol fermentation in A.
fumigatus hypoxia adaptation and fungal virulence by identifying
and characterizing the ethanol fermentation pathway genes in this
pathogen.
Our in vitro molecular genetic analyses strongly suggest that the
main route of ethanol fermentation in A. fumigatus is through the
pyruvate decarboxylase, PdcA, and subsequent alcohol dehydro-
genase, AlcC. Null mutants in both of these genes were unable to
Figure 10. Cytokine production in response to A. fumigatus wild type and DalcC inoculation. (A) KC, (B) MIP-2, (C) IL-6, and (D) TNF-a
concentrations were determined in BAL fluids on day 3 post inoculation. Significant differences between the two inoculation groups could be
observed for KC and MIP-2 protein levels. *p,0.05. Results are the mean and standard error of N=5 mice.
doi:10.1371/journal.ppat.1002145.g010
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These results are in agreement with observations in Aspergillus
nidulans, where a pdcA deletion strain also fails to produce ethanol
[61] and alcC activity is induced by hypoxic conditions [62].
However, our results also suggest that ethanol fermentation per se
is not required for fungal growth in vitro as none of the ethanol
fermentation deficient strains displayed any growth differences in
in vitro normoxic or hypoxic growth conditions. We cannot
definitively rule out that a small amount of undetectable ethanol
fermentation still occurs in our mutant strains, however, we feel it
is more likely that other fermentation pathways exist and/or that
sufficient mitochondrial respiration still occurs under the condi-
tions examined to support robust growth.
Despite the persistent growth of the ethanol fermentation
deficient stains under hypoxia, the DalcC displayed a very different
phenotype in vivo in our murine models of IPA. In our three
immunologically distinct models of IPA, no difference in mortality
could be observed in mice infected with the wild type and ethanol
fermentation mutant strains. However, histopathology of the
chemotherapy and Triamcinolone models indicated an increased
influx of immune cells and reduced fungal growth in DalcC
inoculated mice. These observations were confirmed by flow
cytometry and differential cell counts as well as quantitative fungal
burden measurements by qRT-PCR. Although, we observed less
fungal burden in DalcC inoculated mice, the overall lesion size was
comparable to wild type caused lesions and both strains caused the
same level of tissue damage as measured by LDH and Albumin
assays. This result is probably due to the increased influx of
neutrophils and macrophages to sites of DalcC infection. It is
tempting to speculate then that DalcC inoculated mice might
succumb to the infection because of the increased host
Figure 11. Decreased fungal burden in DalcC inoculated mice.
Outbred CD1 mice were immunosuppressed by subcutaneous injection
of triamcinolone (40 mg/kg) 1 day prior to A. fumigatus inoculation in a
Hinner’s inhalation chamber. Fungal burden in the lungs was
determined by quantitative real-time PCR based on the 18S rRNA gene
of A. fumigatus. Data are presented as total fungal genomic DNA
normalized to input DNA. The mean and standard error are presented
(N=3 mice for the control group and N=7 mice for both inoculation
groups). * p,0.01.
doi:10.1371/journal.ppat.1002145.g011
Figure 12. Wild type levels of tissue damage in DalcC inoculated mice. (A) BAL albumin and (B) BAL lactate dehydrogenase (LDH) levels in
Triamcinolone immunosuppressed CD1 mice (40 mg/kg 1 day prior to infection) were determined on day 3 and 4 p. i. in wild type (CEA10) and DalcC
inoculated mice demonstrating no significant differences between inoculation groups.
doi:10.1371/journal.ppat.1002145.g012
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mold. The decrease in fungal burden in mice infected with the
DalcC strain might suggest that this response is partially effective at
limiting fungal growth, but with collateral damage to the host that
results in mortality. Of note, Mehrad et al. recently observed that
an overproduction of KC results in a lower fungal burden and
higher levels of neutrophil recruitment in a murine model of IPA,
which leads to more resistance to A. fumigatus infections [63]. As we
observed increases in KC and MIP2 levels in response to DalcC
with a concomitant decrease in fungal burden, it may be possible
that the increased inflammatory response to DalcC is at least
partially antifungal.
The in vivo phenotype of DalcC raises some intriguing questions
about the mechanism behind the observed increase in host
inflammatory response and subsequent reduction in fungal
burden. Previous observations have indicated that ethanol is a
potent immunosuppressive agent, and thus it seems reasonable to
hypothesize that loss of ethanol production at the site of infection
Figure 13. Increased cytokine response is not caused by cell wall changes of the DalcC strain. Secretion of MIP-2 and TNF-a by bone
marrow-derived macrophages (cultured as described in Materials and Methods) incubated for 18 hours with A. fumigatus conidia (A), UV irradiated
germlings (B), or UV irradiated hyphae (C). Presented are the average concentration and standard deviation in 3 wells per condition of one
representative experiment. P.0.05 for all comparisons.
doi:10.1371/journal.ppat.1002145.g013
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[48,49,52,64,65,66,67,68]. Acute and chronic ethanol exposures
have been shown to alter the immune response to both bacterial
and viral pathogens [69,70,71]. Ethanol decreases clearance of
pneumococci and Klebsiella species from the lungs of ethanol-fed
mice, which is mainly due to an impaired response of the
phagocytic cells [72]. With regard to fungal pathogens, Zuiable
et al. observed that human blood monocytes incubated with
ethanol have impaired killing of Candida albicans [51]. Along these
lines of thinking it may be possible that A. fumigatus is able to
partially suppress localized host immune responses by utilizing
ethanol fermentation in response to hypoxic microenvironments
during IPA. However, to confirm this hypothesis, more sensitive
detection methods for the localized and low levels of ethanol
produced at the site of A. fumigatus infection are needed.
Currently, ethanol detection in our murine models is inconsis-
tent as exhibited by our initial experiment with BALs and
1H-
NMR. BALs only sample the airway and do not sample localized
infection sites located in the lung parenchyma so it is potentially
not surprising that this method may not consistently detect a small
molecule in the lung such as ethanol. To overcome this potential
limitation, we attempted to utilize whole lung homogenates and
two different ethanol detection methods including an enzymatic
based approach and a GC-MS approach. Unfortunately, either
the complexity of the samples, the chemical nature of ethanol
itself, or the metabolism at the site of infection prevented
reproducible detection of ethanol. Thus, currently, we cannot
directly attribute the increased inflammatory response observed
with DalcC to loss of ethanol production. However, development of
more sensitive detection methods is underway in our laboratory.
It is intriguing to note that the possibility of fermentation being
important for hypoxic growth during fungal infections is further
supported by the finding of ethanol in cerebral tissue of rats
infected with C. neoformans [73]. Moreover, in support of the
hypothesis that it is at least a secreted factor that is affecting the
host response to DalcC, UV killed wild type and DalcC strains at 3
distinct growth phases do not exhibit a difference in pro-
inflammatory responses ex vivo with bone marrow derived
macrophages (Figure 13). Thus, the most likely culprit for an
altered inflammatory response, the fungal cell wall, appears to not
be altered in DalcC. Future studies will continue to probe the
mechanism behind the reduced fungal growth and increased
inflammatory response of DalcC.
Altogether, in this study we present the first in vivo observations
of hypoxic microenvironments during an invasive pulmonary
fungal infection and shed light on how the mold A. fumigatus adapts
to low oxygen environments to cause disease. These results, along
with other published data from our laboratory, continue to
support the hypothesis that hypoxia adaptation and growth is an
important component of the pathogenesis of IPA [29,31,74]. Our
results further emphasize the dynamic and complex interactions
that occur between fungi and their hosts during an invasive
pulmonary fungal infection. Future studies will continue to explore
the effects of infection localized microenvironment stresses on
invasive pulmonary aspergillosis pathogenesis. It will be intriguing
to learn if other human fungal pathosystems also involve
significant levels of hypoxia at sites of infection and whether
ethanol fermentation pathway mutants also alter the host response.
Materials and Methods
Strains and media
A. fumigatus strain CEA17 (gift from Dr. J.P. Latge ´, Institut
Pasteur, Paris, France) was used to generate the pdcA (AFUB_
038070; DpdcA::A. parasiticus pyrG pyrG1), pdcB (AFUB_096720;
DpdcB::A. parasiticus pyrG pyrG1), pdcC (AFUB_062480; DpdcC::A.
parasiticus pyrG pyrG1), and alcC (AFUB_053780; DalcC::A. parasiticus
pyrG pyrG1) null mutant strains. A. fumigatus strain CEA17 is a
uracil-auxotrophic (pyrG1) mutant of A. fumigatus strain CEA10
[75,76]. In this study, we used CEA10 (CBS144.89) (gift from Dr.
J.P. Latge ´, Institut Pasteur, Paris, France) as the wild type strain in
all experiments except the
1H-NMR metabolite profiling exper-
iment which utilized strain AF293, DpdcA, DpdcB, DpdcC, DalcC,
and the ectopic complemented control strains, pdcA recon
(DpdcA::A. parasiticus pyrG + pdcA) and alcC recon (DalcC::A.
parasiticus pyrG + alcC). All strains were routinely grown in glucose
minimal medium (GMM) with appropriate supplements as
previously described [77] at 37uC. To prepare solid media 1.5%
agar was added before autoclaving.
Strain generation
Generation of the pdc null mutants and the alcC null mutant in
A. fumigatus strain CEA17 were accomplished by replacing the
ORF of the target genes with A. parasiticus pyrG. The replacement
construct was generated by cloning a sequence homologous to the
gene locus into plasmid pJW24 (donated by Dr. Nancy Keller,
University of Wisconsin – Madison). Homologous sequences, each
,1 kb in length and 59 and 39 of the gene coding sequence, were
cloned to flank A. parasiticus pyrG in pJW24. The resulting plasmids,
pPDCAKO, pPDCBKO, pPDCCKO, and pALCCKO, were
used as templates to amplify a disruption construct (3.6–4.7 kb) for
use in fungal transformation.
To complement the DpdcA and DalcC strains the genes were
amplified using genomic DNA of CEA10 as template and primers
,1k b5 9 and ,500 bp 39 of the gene coding sequence. The PCR
products were cloned in front of the hygromycin B resistance gene
into plasmid pBC-hygro (Silar 1995, obtained from the Fungal
Genetics Stock Center, Dr. Kevin McCluskey) using SpeI and
NotI restriction sites [78,79]. The resulting plasmids, pBC-hyrgo-
PDCA and pBC-hygro-ALCC, were used as template to amplify
complementation constructs (,7.4 kb), which were used in a
fungal transformation and selection was for colonies able to grow
on media containing 150 mg/ml hygromycin B. The primers
utilized in vector construction are presented in Table S1.
Standard fungal protoplast transformation was used to generate
mutant and reconstituted strains as previously described [31].
Transformants were initially screened by PCR to identify potential
homologous recombination events at the gene locus using primers
designed to amplify only the mutated gene locus (Table S1). Single
conidia of each transformant were prepared and screened by PCR
to eliminate the chance of heterokaryons. Homologous recombi-
nation was confirmed by Southern analysis with the digoxigenin
labeling system (Roche Molecular Biochemicals, Mannheim,
Germany) as previously described [80].
Hypoxic cultivation
Strains were grown on or in GMM at 37uC. Normoxic
conditions were considered general atmospheric levels within the
lab (,21%). For hypoxic conditions two different devices were
used, a Biospherix C-Chamber with O2 levels controlled by a
PRO-Ox controller and CO2 levels controlled with PRO-CO2
controller (Biospherix, Lacona, NY, USA) and an INVIVO2 400
Hypoxia Workstation (Ruskinn Technology Limited, Bridgend,
UK). For these experiments, the O2 set point was 1% and the CO2
set point was 5%. Oxygen levels were maintained with 94% N2
and a gas regulator. Colony growth was quantified as previously
described [31].
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For normoxic samples, strains were grown in GMM with 1x10
6
conidia/ml, 300 rpm, at 37uC for 16 hrs. 25 ml of the normoxic
culture were mixed with 15 ml of fresh GMM and incubated for
an additional 24 hrs under hypoxic conditions (130 rpm, 37uC).
Mycelia of normoxic and hypoxic cultures were harvested, rinsed
twice with distilled water, transferred to 2 ml screw cap tubes with
0.1 mm glass beats, immediately frozen in liquid nitrogen and
weighed. After adding 1 ml of extraction buffer (100 mM
KH2PO4, 2 mM MgCl2, and 1 mM DTT), the samples were
twice placed in a mini beadbeater (Biospec products, Bartlesville,
OK, USA) for 30 sec with 5 min on ice in between. After
centrifugation (13,000 rpm, 20 min, 4uC) the cell free extracts
were transferred to new, cold reaction tubes and kept on ice until
use. The protein concentration of the cell free extracts was defined
by using the Coomassie Plus – The Better Bradford Assay Kit
(Pierce, Rockford, IL, USA) following the method recommended
by supplier.
Enzyme activity was determined using a method adapted from
Lockington et al. 1997 [61]. The assay volume was adjusted to
200 ml for use in 96-well plates. 25 ml cell free extract (sample and
control) or 25 ml extraction buffer (blank) were added to wells in
duplicates and then 175 ml of the sample mix (50 mM histidine-
HCl, 0.35 mM MgCl2, 0.35 mM TPP, 67 mM pyruvate, 6 U
yeast ADH, 0.5 mM fresh NADH, added up with water to 175 ml)
were added to the samples and the blank, and 175 ml of the control
mix (sample mix without pyruvate) were added to the cell free
extract as controls. The rate of decrease in absorbance at 340 nm
was followed in a Spectramax Plus (Molecular Devices, Sunnyvale,
CA, USA), measuring every 10 sec, at 37uC over 5 min after
mixing for 1 sec.
The pyruvate decarboxylase activity was calculated as described
by http://cmbe.engr.uga.edu/assays/pyruvatedecarboxylase.pdf.
The calculation had to be adjusted to the reduced length of the
light path in the 96-well plate by multiplying the molar extinction
coefficient for NADH (6.22 L/mmol for a path length of 1 cm)
with 0.788. Experiments were done in three separate biological
replicates and the mean and standard error calculated with Prism
software version 5.0b (GraphPad Software Inc.).
Ethanol detection
To detect ethanol in the culture supernatant of in vitro fungal
cultures, high performance liquid chromatography (HPLC) was
performed using a Shimadzu system (Kyoto, Japan), consisting of a
solvent delivery module, a low pressure gradient pump unit, a
degasser, an autoinjector, a column oven and a refractive index.
The column used for the analytical separation was the Aminex
Fermentation Monitoring column (150 mm67.8 mm, BioRad,
Hercules, CA). The mobile phase consisted of 0.001 M H2SO4,
the flow rate was 0.8 ml/min, the column temperature was 60uC,
and the sample injection volume was 25 ml. As external standard
ethanol solutions with known concentration (2, 1, 0.5, 0.1, 0.05,
0.01 (v/v) %) were used in every experiment and a standard curve
was generated and used to determine concentration. Data was
normalized to mycelial dry weight.
In addition, a Shimadzu (Kyoto, Japan) QP2010 GC/MS with
an electron ionization (EI) source was used for metabolite
separation and identification. A 30 m 0.25 mm id 0.25 um film
thickness, RTX-5MS (5% Diphenyl - 95% dimethyl polysiloxane)
fused silica capillary column from Restek (Bellefonte, PA) was used
for all separations. The GC column was temperature programmed
as follows: 5 min isothermal at 100uC, then raised at 20uC/minute
to 120uC, and held for 30 seconds. Helium gas served as the
carrier gas at a flow rate of 0.73 ml/min. Split injections were
performed at a 1 to 20 ratio. The injection port was held constant
at 200uC. The interface temperature was set at 200uC and the ion
source at 200uC. EI fragmentation was performed scanning from
40 to 400 at 0.2 seconds/scan. The instrument was calibrated with
Perfluorotributylamine (PFTBA) prior to analysis. Standards of
ethanol were analyzed for rention time and a response curve using
a 3 point serial dilution. These response curves were used to
calculate detected compounds in each sample. One micro-liter of
each sample and standard was used for analysis. Identification was
matched to NIST 21 and NIST 107 libraries commercially
purchased as well as secondary confirmation with standards,
previously mention, purchased from Sigma (Saint Louis, MO).
For the culture samples, strains were grown as described above
in the pyruvate decarboxylase assay description. After 24/48/72/
96 hrs 2 ml of the culture supernatant were transferred into sterile
reaction tubes on ice, and filtered through a Millipore membrane
filter (0.45 mm, Millipore, Yonezawa, Japan) into HPLC vials (Sun
Sri, Rockwood, TN). Experiments were done in three biological
replications.
Isolation of total RNA and transcriptional profiling
Conidia from freshly harvested GMM plates were inoculated in
5 ml GMM in a 6-well plate to a concentration of 1610
7 conidia/
ml. Cultures were grown aerobically for 24 h. For normoxic
growth, cultures were maintained in atmospheric conditions. For
hypoxic growth, cultures were placed in the hypoxic chamber for
24 h. Fungal mats were flash frozen in liquid nitrogen and
lyophilized prior to disruption using a bead beater. To assess
fungal gene expression in vivo, the triamcinolone immunosuppres-
sion model was utilized as described below. Mice were sacrificed
on day 3 and 4 post inoculation, and lungs were harvested and
immediately frozen in liquid nitrogen. Samples were freeze-dried
and homogenized with glass beads on a Mini-Beadbeater (BioSpec
Products, Inc., Bartlesville, OK, USA). Total RNA was extracted
using TRIsure Reagent (Bioline, Tauton, MA, USA) according to
the manufacturer’s instructions. After treatment with DNase I
(Ambion, Austin, TX, USA), 500 ng of total RNA were used to
generate first-strand cDNA with the reverse transcriptase kit
(Qiagen, Hilden, Germany). Real-time PCR assays were per-
formed with 20 ml reaction volumes that contained 1x iQ SYBR
green master mix (Biorad, Hercules, CA, USA), 0.2 mM of each
primer (Table S1), and 2 ml of a 1:5 dilution of the cDNA using a
Bio-Rad MyiQ single Color real-time PCR detection System with
iCycler. No-RT controls for each primer set were also assayed to
confirm that no DNA contamination was present, respectively.
Real-time PCRs were performed in triplicates, and the expression
levels of all genes of interest were normalized to ß–tubulin levels or
tefA (translation elongation factor alpha subunit) levels for in vivo
experiments. The thermal cycling parameters consisted of a 3-min
Taq polymerase hot start at 95uC, followed by template
amplification of 40 cycles of 95uC for 10 sec, 58uC for 30 sec.
Fluorescence was measured during the annealing/extension step
(58uC) and a disassociation analysis (melting curve) was performed
to confirm that a single amplified product was present. Following
amplification, data was analyzed with the Bio-Rad iQ5 2.0
Standard Edition Optical System Software. The DDCt method of
analysis was used to determine fold changes of gene expression in
the mutants relative to the wild type CEA10 strain.
Murine models of invasive pulmonary aspergillosis
The virulence of the A. fumigatus strains was tested in three
immunologically distinct murine models of invasive pulmonary
aspergillosis. All animals were housed five per cage in an
environment with HEPA filtered air, autoclaved food at libitum,
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clindamycin (150 mg/ml), vancomycin (1 mg/L) and gentamicin
(100 mg/ml). CD1 male and female mice, 6–8 weeks old were
used in all experiments for the triamcinolone and chemother-
apeuatc murine models. Mice were obtained from Charles River
Laboratories (Raleigh, NC) or from a breeding colony located in
the Animal Resources Center (ARC) at Montana State University.
For the Chronic Granulomatous Disease murine model, 6–8 week
old mice with a null allele corresponding to the X-linked gp91
phox
component of NADPH oxidase (B6.129S6-Cyb
btm1Din) were bred
in the ARC at Montana State University [45].
For the triamcinolone (corticosteroid) model mice were
immunosuppressed with a single dose of Kenalog (Bristol-Myers
Squibb Company, Princeton, NJ, USA) injected subcutaneously
(s.c.) at 40 mg/kg 1 day prior to inoculation. For the chemother-
apy model mice were immunosuppressed with intraperitoneal (i.p.)
injections of cyclophosphamide (Baxter Healthcare Corporation,
Deerfield, IL, USA) at 175 mg/kg 2 days prior to inoculation and
with Kenalog injected subcutaneously (s.c.) at 40 mg/kg 1 day
prior to inoculation. On day 3 post-inoculation (p.i.), repeat
injections were given with cyclophosphamide (150 mg/kg i.p.) and
on day 6 p.i. with Kenalog (40 mg/kg s.c.).
For the detection of hypoxia in vivo, 15 unanesthetized mice
inhaled 40 ml of an aerosolized suspension of 1610
9 conidia/ml
of A. fumigatus strain CEA10. 6 uninfected control mice inhaled
40 ml of aerosolized 0.01% Tween 80 in a Hinners inhalational
chamber for 45 min as previously described [81]. One A. fumigatus
infected mouse was sacrificed immediately after infection, lungs
were removed, homogenized and the number of CFU was
determined (,1610
4 conidia per mouse). After hypoxyprobe
injection (see below), mice were sacrificed at set time points after A.
fumigatus challenge and lungs were processed for hypoxyprobe
immunohistochemistry.
For survival studies and histopathology, 10 mice per A. fumigatus
strain (CEA10, DpdcA, pdcA recon., DalcC) either inhaled 40 ml of
an aerosolized suspensions of 1x10
9 conidia/ml (control mice
inhaled 40 ml of aerosolized 0.01% Tween 80) or the animals
were inoculated intranasally with 1610
6 conidia in 25 ml and
monitored twice a day. Infection inoculum was prepared by
growing the A. fumigatus isolates on GMM agar plates at 37uC for 3
days. Conidia were harvested by washing the plate surface with
sterile phosphate-buffered saline 0.01% Tween 80. The resultant
conidial suspension was adjusted to the desired concentration by
hemacytometer count.
Mice were observed for 14 days after A. fumigatus challenge. Any
animals showing distress were immediately sacrificed and recorded
as deaths within 24 hrs. No mock infected animals perished in
either murine model in all experiments. Lungs from all mice
sacrificed on different time points during the experiment were
removed for fungal burden assessment, infiltrate and cytokine
analysis as well as histopathology. Animal experiments were all
repeated in duplicate.
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
animal experimental protocol was approved by the Institutional
Animal Care and Use Committee (IACUC) at Montana State
University (Federal-Wide Assurance Number: A3637-01).
Histopathology
For histopathology, CD1 mice were inoculated as described
above, and sacrificed at set time points after A. fumigatus challenge.
When mice were sacrificed, lungs were removed on that day. Lung
tissue was fixed in 10% phosphate-buffered formalin, embedded in
paraffin, sectioned at 5 mm, and stained with hematoxylin and
eosin (H&E) or Gomori methenamine silver (GMS) by using
standard histological techniques. Microscopic examinations were
performed on a Nikon Eclipse 80i microscope and imaging system
(Nikon Instruments Inc., Melville, NY, USA). A total of 3 mice
were examined at each respective time point.
1H-NMR metabolite profiling of broncheoalveolar lavage
fluid
The chemotherapeutic murine model of IPA was utilized in
these experiments. Mice were inoculated in the Hinner’s chamber
with either 0.01% Tween 80 or A. fumigatus wild type strain AF293.
A total of 10 mice were used in each treatment group. On day +3
post infection, BALs were performed with each BAL a final total
volume of ,1.5 ml. Deuterated water was added to 600 mLo f
each BAL to provide a field frequency lock and an internal
standard of 0.03% 3-(Trimethylsilyl)-Propionic acid-D4 sodium
salt (TSP) was added to each sample to provide a chemical shift
reference at 0 ppm. For
1H-NMR, a one-pulse sequence was used
with a 2-second pre-saturation pulse and 7-second repetition time.
The resulting one-dimensional spectra were compared using
MestReC NMR analysis software (Mestrelab Research) to monitor
the presence and absence of identifiable metabolites.
Hypoxyprobe – treatment, staining and
immunohistological identification
Mice were intravenously injected with hypoxyprobe at a dose of
60 mg/kg weight of the mouse (Hypoxyprobe Inc., Burlington,
MA, USA). After 60 to 90 min, mice were sacrificed by
pentobarbital anesthesia (100 mg/g body weight) followed by
exsanguination. The left lung of each mouse was filled with OCT
(frozen tissue matrix) and after embedding in OCT immediately
frozen in liquid nitrogen. The lungs were cryosectioned into 5 mm
sections and stored at 280uC until stained. After thawing, the
sections are fixed in cold acetone (4uC) for 15 min, followed by
washing the sections (PBS, 265 min) and blocking with normal
serum block (NSB: PBS +10% goat serum +1.25% mouse serum)
at RT. After 30 min, sections were washed and incubated
overnight at 4uC with the mouse monoclonal antibody FITC-
Mab1 (Hypoxyprobe-1 Plus Kit, Hypoxyprobe Inc., Burlington,
MA, USA) diluted 1:400 in NSB and with a rabbit polyclonal
antibody to Aspergillus (Abcam Inc., Cambridge, MA, USA).
Aspergillus isotype control slides were incubated only with FITC-
Mab1 and hypoxyprobe isotype control slides only with the
Aspergillus antibody. Isotype controls are a measure of unspecific
staining of the secondary antibody. After another wash, sections
were incubated for 60 min at room temperature with DyLight
594-conjugated mouse Anti-FITC (Jackson ImmunoResearch
Laboratories, West Grove, PA) and AlexaFluor488-conjugated
goat Anti-rabbit (Invitrogen, Carlsbad, CA, USA) diluted 1:400.
After another washing step, prolong Gold antifade reagent with
DAPI (Invitrogen, Carlsbad, CA, USA) was added to each section.
Microscopic examinations were performed on a Zeiss Axioscope
2-plus microscope and imaging system (Zeiss, Jena, Germany). For
each time point, a total of 2 to 4 mice were examined and
experiments were repeated in triplicate.
Evaluation of pulmonary infiltrate by flow cytometry and
cell differentiation
Broncheoalveolar lavages (BALs) were performed by intratra-
cheal instillation and extraction of 3 ml 1x PBS. Total lung lavage
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onto glass slides, and stained with Diff-Quick (Fisher Scientific,
Pittsburgh, PA, USA) for differential counting. For flow cytometry,
BAL cells were centrifuged and resuspended in phosphate-
buffered saline with 2% calf serum and an anti-mouse Fc receptor
antibody (Trudeau Institute, Saranac Lake, NY, USA) to a
concentration of approximately 10
7 cells/ml. The cells were then
stained with a mixture of fluorophore-conjugated antibodies
against mouse GR-1 (APC-Cy7) (BD Pharmingen, San Diego,
CA, USA), F4/80 (PE-Cy7) (eBioscience, San Diego, CA, USA),
CD11b (AlexaFluor700) (BioLegend, San Diego, CA, USA), and
CD11c (APC) (purified from the hamster cell line N418 (ATCC,
Manassas, VA, USA) and fluorophore-conjugated using the
AlexaFluor633 protein labeling kit (Invitrogen, Carlsbad, CA,
USA)) and then examined on a BD LSR flow cytometer (BD
Biosciences, San Jose, CA, USA). Analysis of cytometry data was
performed with FlowJo software Version 8.8.7 DMG and numbers
of relevant cell types were determined by combining flow
cytometry data (percentage of a given cell type) with BAL cell
counts. Data presented are the mean and standard error of N=5
mice at each time point.
Detection of cytokines, chemokines and other signal
proteins in BAL fluids
The BD Cytometric Bead Array Mouse Inflammation Kit (BD
Biosciences, San Jose, CA, USA) was used according to the
manufacturers instructions to quantitatively measure IL-6, IL-10,
MCP-1, IFN-c, TNF-a, and IL-12p70 protein levels in mouse
BAL fluids utilizing a FACSCalibur flow cytometer (Becton
Dickinson, Mountain View, CA, USA). IL-17, MIP-2, KC, and
VEGF levels in mouse BAL samples were determined using the
mouse cytokine/chemokine Milliplex Map Kit (Millipore Corpo-
ration, Billerica, MA, USA) according to the manufacturers
instructions and then examined and analyzed on the BioPlex 200
System (Bio-Rad, Hercules, CA, USA). Data presented are the
mean and standard error of N=5 mice at each time point.
Determination of LDH and Albumin levels in BAL fluids
In vivo lung tissue damage was determined by measurement of
LDH and Albumin levels in mouse BAL samples by using a LDH
assay (CytoTox 96 Non-Radioactive Cytotoxicity Assay, Promega,
Madison, WI, USA) and an albumin assay (Albumin (BCG)
Reagent Set, Eagle Diagnostics, Cedar Hill, TX, USA) according
to the manufacturers’ instructions.
Determination of in vivo fungal burden
To assess fungal burden in lungs, the triamcinolone immuno-
suppression model was utilized as described above. Mice were
sacrificed on day 3 and 4 post inoculation, and lungs were
harvested and immediately frozen in liquid nitrogen. Samples
were freeze-dried, homogenized with glass beads on a Mini-
Beadbeater (BioSpec Products, Inc., Bartlesville, OK, USA), and
DNA extracted with the E.N.Z.A. fungal DNA kit (Omega Bio-
Tek, Norcross, GA, USA). Quantitative PCR was performed as
described previously [82].
In vitro cytokine response
Bone marrow cells were eluted from the tibias and femurs of 8–
12 week old C57BL/6 mice, lysed of red blood cells, and cultured
in RP20 (RPMI, 20% FCS, 5 mM HEPES buffer, 1.1 mM L-
glutamine, 0.5 U/ml penicillin, and 50 mg/ml streptomycin)
supplemented with 30% (v/v) L929 cell supernatant (source of
M-CSF). Bone marrow cells were plated in a volume of 20 ml at a
density of 2.5610
6 cells/ml in 10 ml Petri dishes. The medium
was exchanged on day 3. Adherent bone marrow-derived
macrophages (BMMØs) were harvested on day 6. Cells were
washed and plated in 0.2 ml RP10 at a density of 5610
5 cells/ml
in 96 well plates and stimulated for 18 hours with conidia (5610
5
per well), UV irradiated germlings (10
5/well), or UV irradiated
hyphae (2610
4/well) prepared as described before [83]. After
18 hours co-culture supernatants were collected for ELISA.
Commercially available ELISA kits for TNF (BD Biosciences,
San Jose, CA, USA) and MIP-2 (R&D Systems, Minneapolis, MN,
USA) were used according to the manufacturers’ instructions.
Supporting Information
Figure S1 Representative 400 MHz
1H-NMR spectra of
broncheoalveolar lavage (BAL) fluid from a mouse with a day
+3 A. fumigatus pulmonary infection (top spectra) or an uninfected
mouse (bottom spectra). Known metabolites are labeled on the
infected mouse spectra. Substantial amounts of ethanol are seen in
the infected mouse samples.
(TIF)
Figure S2 Hypoxic microenvironments at the site of A. fumigatus
infection. Single color channel pictures were merged to show
overlapping localization of fungal tissue (green), hypoxia (red), and
inflammation (DAPI stained nuclei).
(TIF)
Figure S3 Representative histopathology of X-CGD mice
inoculated with wild type (CEA10) or DalcC conidia using a
Hinner’s inhalational chamber. Mice were euthanized on
indicated days p.i., lungs removed, fixed, and stained with
hematoxylin and eosin (H&E) or Gommori’s methenamine silver
(GMS) stain. Lung histopathology showed strongly reduced fungal
growth of both strains with simultaneous massive inflammation.
No difference could be observed between infection groups.
Bar=100 mm.
(TIF)
Figure S4 Flow cytometry Dot plot for F4/80 and CD11c.
(TIF)
Figure S5 Flow cytometry Dot plot for GR-1 and CD11b.
(TIF)
Table S1 Nucleotide sequences of primers used for deletion and
complementation strain constructions as well as real-time PCR.
(XLS)
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